Clinical and neuropathological differences between Parkinson's disease, Parkinson's disease dementia and dementia with Lewy bodies – current issues and future directions-Reference-Cited by-同舟云学术

Clinical and neuropathological differences between Parkinson's disease, Parkinson's disease dementia and dementia with Lewy bodies – current issues and future directions

Published:2019-04-23 Issue:5 Volume:150 Page:467-474
ISSN:0022-3042
Container-title:Journal of Neurochemistry
language:en
Short-container-title:J. Neurochem.

Author:

Walker Lauren¹^ORCID,Stefanis Leonidas²³,Attems Johannes¹

Affiliation:

1. Institute of Neuroscience Campus for Ageing and Vitality Newcastle University Newcastle‐upon‐Tyne UK

2. First Department of Neurology National and Kapodistrian University of Athens Medical School Athens Greece

3. Biomedical Research Foundation of the Academy of Athens Athens Greece

Funder

Alzheimer's Society

Medical Research Council

Publisher

Wiley

Subject

Cellular and Molecular Neuroscience,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jnc.14698

Reference68 articles.

1. Staging of Neurofibrillary Pathology in Alzheimer's Disease: A Study of the BrainNet Europe Consortium

2. Quantitative neuropathological assessment to investigate cerebral multi-morbidity

3. Tau Enhances α-Synuclein Aggregation and Toxicity in Cellular Models of Synucleinopathy

4. Differences in neuropathologic characteristics across the Lewy body dementia spectrum

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dopamine transporter positron emission tomography in patients with Alzheimer’s disease with Lewy body disease features;Neurobiology of Aging;2024-02

2. Deciphering the role of nanocarrier-based nucleic acid delivery to the brain for the management of neurodegenerative disorders;Journal of Drug Delivery Science and Technology;2024-02

3. Prevalence of Concomitant Pathologies in Parkinson’s Disease: Implications for Prognosis, Diagnosis, and Insights into Common Pathogenic Mechanisms;Journal of Parkinson's Disease;2024-01-23

4. Accumulation of aggregated alpha-synuclein in neural tissue structures in neurodegenerative diseases;Acta Biomedica Scientifica;2024-01-15

5. Toxic interactions between dopamine, α-synuclein, monoamine oxidase, and genes in mitochondria of Parkinson’s disease;Journal of Neural Transmission;2024-01-09